1. HBW Insight
  2. >>Wellness
  3. >>Business

Infant Formula Production Stalls On Reckitt Benckiser's Latest Stumble

 
• By Malcolm Spicer

A "technical problem" interrupted infant formula production at firm's Netherlands plant during third quarter, causing a 8% dive in its revenues from Enfamil and other brand formulas. The problem has been corrected but revenues will be slowed during the current quarter and likely into early 2019.  But analysts say the imapct could be deeper impact because it's the fourth problems since 2011 RB should have avoided.

Reckitt Benckiser Group PLC's move into infant formula production as a cornerstone for raising its consumer health profile could instead be the source of the latest problem that could sour investors on the firm's chances.

A "technical problem" interrupted production of infant formula and other children's nutritional at the UK firm's plant in the Netherlands...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Business

PLT Health Wants Sports Nutrition Marketers To Know Consumers Like ‘Feeling Good’

 
• By Malcolm Spicer

Nutritional ingredient developer publishes results survey, with responses from 546 men and women in five countries, in a report looking at trends in cognitive and mood and with findings on consumers’ active nutrition goals, with a focus on the “concept of feeling good.”

Complementary Medicine Move Paying Off For Galenica

 
• By Tom Gallen

Galenica's Swiss consumer health business Verfora is reaping the rewards of its expansion in the complementary medicine market with a solid showing in the first half of the year.

Subscription Plot Twist Featured In Herbalife’s ‘Next Chapter’ With Pro2col Digital Platform

 
• By Malcolm Spicer

More than 7,000 distributors started a beta iteration of Pro2col in July Platform’s availability to additional US distributors =is planned for October, when it will launch with a Herbalife brand name.

UK’s ProBiotix Health Launches Menopause And Post-Menopause Supplements

 
• By David Ridley

YourBiotixMH and YourBiotixPMH “offer unique multi-positioning functionality, targeting not only cardiovascular health but also addressing key health risks associated with menopause and post-menopause, including mood imbalances, psychological challenges and bone loss,” according to ProBiotix Health.

More from Wellness

EFSA: ‘A Dose Of Estragole Without A Harmful Effect Cannot Be Established’

 
• By David Ridley

Dietary supplements containing estragole may have to be removed from the European Union market due to carcinogenic risk, according to a draft scientific opinion from EFSA that is currently out for consultation.

Complementary Medicine Move Paying Off For Galenica

 
• By Tom Gallen

Galenica's Swiss consumer health business Verfora is reaping the rewards of its expansion in the complementary medicine market with a solid showing in the first half of the year.

Subscription Plot Twist Featured In Herbalife’s ‘Next Chapter’ With Pro2col Digital Platform

 
• By Malcolm Spicer

More than 7,000 distributors started a beta iteration of Pro2col in July Platform’s availability to additional US distributors =is planned for October, when it will launch with a Herbalife brand name.